Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkae319
Abstract: Abstract Background Darunavir is a potent HIV protease inhibitor with a high barrier to resistance. We conducted a nested pharmacokinetic sub-study within CHAPAS-4 to evaluate darunavir exposure in African children with HIV, taking once-daily darunavir/ritonavir… read more here.
Keywords: african children; darunavir; ritonavir second; children hiv ... See more keywords